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Skeletal muscle atrophy is a critical component of the ageing process. Age-related muscle
wasting is due to disrupted muscle protein turnover, a process mediated in part by the
ubiquitin proteasome pathway (UPP). Additionally, older subjects have been observed
to have an attenuated anabolic response, at both the molecular and physiological levels,
following a single-bout of resistance exercise (RE). We investigated the expression levels
of the UPP-related genes and proteins involved in muscle protein degradation in 10 older
(60–75 years) vs. 10 younger (18–30 years) healthy male subjects at basal as well as
2 h after a single-bout of RE. MURF1, atrogin-1 and FBXO40, their substrate targets
PKM2, myogenin, MYOD, MHC and EIF3F as well as MURF1 and atrogin-1 transcriptional
regulators FOXO1 and FOXO3 gene and/or protein expression levels were measured via
real time PCR and western blotting, respectively. At basal, no age-related difference was
observed in the gene/protein levels of atrogin-1, MURF1, myogenin, MYOD and FOXO1/3.
However, a decrease in FBXO40 mRNA and protein levels was observed in older subjects,
while PKM2 protein was increased. In response to RE, MURF1, atrogin-1 and FBXO40
mRNAwere upregulated in both the younger and older subjects, with changes observed in
protein levels. In conclusion, UPP-related gene/protein expression is comparably regulated
in healthy young and old male subjects at basal and following RE. These findings suggest
that UPP signaling plays a limited role in the process of age-related muscle wasting.
Future studies are required to investigate additional proteolytic mechanisms in conjunction
with skeletal muscle protein breakdown (MPB) measurements following RE in older vs.
younger subjects.
Keywords: skeletal muscle, resistance exercise, muscle protein breakdown, ubiquitin-proteasome, atrogene
signaling
INTRODUCTION
Maintaining skeletal musclemass is a critical component of health
and sustaining life. Age-related skeletal muscle wasting is a prefer-
ential loss of type II muscle fibers (Lexell and Taylor, 1991; Lexell,
1995; Kadi et al., 2004; Verdijk et al., 2007), resulting in a pro-
gressive decline in muscle mass, strength and function (Evans,
1995b; Deschenes, 2004). On average, 0.5–1.0% of muscle mass
is lost per year from 40 years of age, with the loss of muscle
mass rapidly increasing after 65 years of age (Greenlund and
Nair, 2003). Age-related muscle wasting reduces functional inde-
pendence (Cooper, 1997) and increases the risk of falls, chronic
metabolic disease (obesity, type 2 diabetes) (Park et al., 2006) and
ultimately, mortality (Mahoney et al., 1994; Newman et al., 2006).
A better understanding of the molecular mechanisms involved
in the decline of muscle mass as we age is therefore required
to aid the development of effective countermeasures to prevent,
attenuate and/or reverse this process.
In healthy individuals, muscle mass is maintained via the
finely regulated balance existing between muscle protein synthe-
sis (MPS) and muscle protein breakdown (MPB). An increase
in muscle mass is largely due to an increase in the size of
pre-existing muscle fibers via net accretion of muscle sarcoplas-
mic and myofibrillar proteins (Goldberg, 1969; Roman et al.,
1993; Staron et al., 1994; Mccall et al., 1996). In contrast, the
ubiquitin proteasome pathway (UPP) is one of the major mecha-
nisms responsible for human MPB (Passmore and Barford, 2004;
Sandri, 2013). The muscle-specific E3-ubiquitin ligases, muscle
ring finger-1 (MURF1) and atrogin-1 [muscle atrophy F-box
(MAFbx), FBXO32] (Bodine et al., 2001; Gomes et al., 2001)
are transcriptionally regulated by Forkhead box O (FOXO) fam-
ily members, FOXO1 and FOXO3 (Brunet et al., 1999; Sandri
et al., 2004; Stitt et al., 2004). Known substrate targets of MURF1
include pyruvate kinase M2 (PKM2) (Hirner et al., 2008) and
myosin heavy chain (MHC) (Clarke et al., 2007; Fielitz et al.,
2007; Cohen et al., 2009), whereas known substrate targets
of atrogin-1 include elongation initiation factor 3 subunit 5
(EIF3F) (Lagirand-Cantaloube et al., 2008), MYOD (Tintignac
et al., 2005) and myogenin (MYOG) (Jogo et al., 2009). These
substrate targets are proteins involved in biological processes
essential to muscle health and function, such as MPS (EIF3F),
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(Lagirand-Cantaloube et al., 2008), development and regenera-
tion (MYOD and MYOG) (Tintignac et al., 2005; Jogo et al.,
2009), metabolism (PKM2) (Hirner et al., 2008) as well as struc-
ture and contraction (MHC) (Clarke et al., 2007; Fielitz et al.,
2007; Cohen et al., 2009).
Resistance exercise (RE) training increases muscle mass,
strength and function (Roman et al., 1993; Staron et al., 1994;
Hortobagyi et al., 1996; Mccall et al., 1996; Wernbom et al., 2007)
and is often used as an intervention to improve muscle functional
capacity (Evans, 1995a). The principal response after a single-
bout of RE is a rapid (within 2–4 h) transient increase in MPS,
particularly in myofibrillar MPS (Phillips et al., 1997). However,
MPB also increases following RE, albeit to a lesser extent and of
a shorter-lived duration than MPS (Biolo et al., 1995; Phillips
et al., 1997). While the aetiology of aged-related muscle atrophy
is multifactorial, a disruption in the regulation of skeletal mus-
cle protein turnover seems to play a major role (Boirie, 2009).
Despite early reports of a large decrease in the basal rate of MPS
(Welle et al., 1993, 1995; Balagopal et al., 1997; Hasten et al., 2000)
and a large increase in the basal rate of MPB (Trappe et al., 2004)
in older compared to younger individuals, recent studies demon-
strate little or no significant difference in basal MPS and MPB
between older vs. younger individuals (Volpi et al., 1999, 2000,
2001; Hasten et al., 2000; Paddon-Jones et al., 2004; Cuthbertson
et al., 2005; Katsanos et al., 2005, 2006; Rasmussen et al., 2006;
Kumar et al., 2009). RE-induced stimulation of MPS occurs in
both younger and older individuals (Yarasheski et al., 1993; Welle
et al., 1994; Volpi et al., 1999; Hasten et al., 2000; Sheffield-Moore
et al., 2004), but with an attenuated magnitude in older individ-
uals (Kumar et al., 2009); a phenomenon referred to as anabolic
resistance. However, the regulation of MPB in older vs. younger
individuals in response to RE and how this may contribute to
anabolic resistance is not well defined. In particular, the gene and
protein expression pattern of the members of the UPP pathway
at rest and following RE in older and younger individuals has
received little attention to date. Such investigations will provide a
better understanding of the activation and regulation of the UPP
pathway in older vs. younger individuals. A greater activation of
the proteolytic markers in older subjects may indicate an increase
in MPB; a phenomenon that might therefore contribute to the
attenuated MPS response characteristic of anabolic resistance.
Conflicting results have been observed in the age-related
mRNA regulation of MURF1 and atrogin-1 (FBXO32), sugges-
tive of gender, muscle type and species influences (rodent vs.
human muscle). Compared to younger rodent muscle, studies
have shown that baseline MURF1 and atrogin-1 mRNA levels in
aged rodents increase in the tibialis anterior (Clavel et al., 2006),
decrease in the gastrocnemius muscle (Edstrom et al., 2006) or
do not differ in the extensor digitorum longus and soleus muscle
(Gaugler et al., 2011). In humans, some studies find an increase in
MURF1 baseline mRNA expression in older muscle compared to
youngermuscle (Raue et al., 2007; Dalbo et al., 2011;Merritt et al.,
2013), while other groups report no differences (Welle et al., 2003;
Whitman et al., 2005; Léger et al., 2008; Greig et al., 2011; Fry
et al., 2013) Albeit one study showing a subtle elevation in base-
line atrogin-1mRNA expression with ageing (Merritt et al., 2013),
age-related differences in basal atrogin-1 mRNA expression do
not occur (Welle et al., 2003; Whitman et al., 2005; Raue et al.,
2007; Léger et al., 2008; Dalbo et al., 2011; Greig et al., 2011; Fry
et al., 2013; Sandri et al., 2013). In response to single-bout RE
in human muscle, MURF1 mRNA increases in both younger and
older subjects 3–6 h post-RE (Raue et al., 2007; Fry et al., 2013).
Atrogin-1 mRNA is either unchanged between older vs. younger
individuals (Fry et al., 2013), or increases 4 h post-single-bout
RE in older individuals only (Raue et al., 2007). Although the
effect of RE on MURF1 and atrogin-1 expression has been well
described (for review see Russell, 2010), whether the protein lev-
els of muscle-specific E3-ubiquitin ligases as well as their substrate
targets are differentially altered in younger vs. older individuals in
human skeletal muscle in response to RE is yet to be investigated.
Therefore, the aim of the current study was to report the
gene and protein expression patterns of MURF1, atrogin-1 and
FBXO40, a gene encoding another muscle specific F-box protein
(Ye et al., 2007), the substrate targets PKM2, myogenin, MYOD,
MHC and EIF3F as well as MURF1 and atrogin-1 transcriptional
regulators FOXO1 and FOXO3 in older vs. younger individuals at




Ten younger (18–30) and 10 older (60–75) healthy males par-
ticipated in the study. The study was approved by the Deakin
University Human Research Committee (#2011-043) in accor-
dance to the Declaration of Helsinki (2013)1. All participants gave
their informed consent and agreed to engage in muscle biop-
sies and physiological testing. The subjects were physically active
but had not participated in a RE training programme within 6
months prior to the study. Exclusion criteria included any type
of protein supplementation and anabolic steroids. Physiological
characteristics of the subjects are summarized in Table 2.
DUAL-ENERGY X-RAY ABSORPTIOMETRY SCAN (DXA)
Total body and regional (arms and legs) body composition [lean
mass (LM), fat mass (FM) and% body fat] and lumbar spine (L1-
L4) and proximal femur (femoral neck and total hip) areal bone
density (aBMD) were assessed via DXA (Lunar Prodigy, GE Lunar
Corp., Madison WI), using software version 12.30.008.
PRELIMINARY TESTING
At least 2 weeks prior to the single-bout exercise session, the
subjects were familiarized with the equipment (Nautilus Leg
Extension, Fitness Generation, Rowville, Australia) and correct
lifting technique. Their one-repetition-maximum (1RM) was
determined using a 5 RM test for leg extension exercise. Estimated
1 RM was then calculated using the Brzycki equation:
1RM = weight lifted (kg) /1.0278 − [reps to fatigue × 0.0278]
(Nascimento et al., 2007).
1http://www.wma.net/en/30publications/10policies/b3/
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MUSCLE BIOPSIES
Skeletal muscle samples were obtained under local anesthesia (1%
Xylocaine) from the belly of the vastus lateralis muscle using a
percutaneous needle biopsy technique (Bergstrom, 1962) modi-
fied to include suction (Evans et al., 1982). Following an incision
through the skin, muscle biopsies were taken using a Bergstrom
needle. The muscle samples were immediately frozen in liquid
nitrogen and used for RNA and protein extraction.
SINGLE-BOUT EXERCISE PROTOCOL
Subjects had been instructed to abstain from strenuous exercise,
caffeine and alcohol consumption for 24 h prior to the trial. One
night before the trial, the subjects were instructed to consume a
provided standardized meal containing 20% fat, 14% protein and
66% carbohydrate. The subjects arrived after an overnight fast
and rested in the supine position for 2 h prior to the sampling of
the 1st muscle biopsy. Immediately following the muscle biopsy,
subjects completed a 3-min light cycling warm-up followed by
a leg extension exercise session. The single-bout exercise proto-
col consisted of three sets of 14 repetitions at 60% of maximal
voluntary contraction (60% 1RM) with 2-min recovery between
sets. Immediately following this, subjects completed another 3-
min light cycling exercise, and were thereafter instructed to rest in
the supine position again. Two hours post-exercise, another mus-
cle biopsy was taken from the opposite leg to avoid any local effect
of the pre-exercise biopsy.
PROTEIN EXTRACTION ANDWESTERN BLOTTING
Total protein from whole tissue lysates was extracted using
RIPA buffer (Millipore, North Ryde, Australia) with 1µL/mL
protease inhibitor cocktail (Sigma, Castle Hill, Australia)
and 10µL/mL Halt Phosphatase Inhibitor Single-Use Cocktail
(Thermo Scientific, Rockford, USA). Total protein content
was determined using the BCA Protein Assay Kit (Pierce
Biotechnology, Rockford, USA) according to the manufacturer’s
instructions. Proteins were separated by SDS-polyacrylamide
gel (PAGE) in a buffer containing 12mM Tris-HCl (pH 8.8),
200mM glycine and 0.1% SDS. Proteins were transferred onto
an Immobilon-FL PDVF membrane (Millipore, Billerica, MA)
in a Bjerrum buffer containing 50mM Tris, 17mM glycine
and 10% methanol. Membranes were blocked with 5% BSA
in PBS for 1 h at room temperature and were thereafter
incubated at 4◦C overnight with the following primary anti-
bodies diluted in 5% BSA in PBS: MURF1 (MP3401, ECM
Biosciences, Versailles, KY) at 1:1000; FBXO40 (H00051725-
B01P, Abnova, Taipei City, Taiwan) at 1:200; FOXO1 (C29H4,
Cell Signaling Technology, Danvers, MA) at 1:500; and FOXO3
(ab17026, Abcam, Cambridge, MA, USA) at 1:500; EIF3F (Jomar
Bioscience, Adelaide, Australia) at 1:500; MYOD (M-318: sc-760,
Santa Cruz Biotechnology) at 1:200; myogenin (MAB3876,Merck
Millipore, Billerica, MA) at 1:300; PKM2 (3198, Cell Signaling
Technology, Danvers, MA) at 1:1000; and MHC/ sarcomeric
myosin (MF 20, Developmental Studies Hybridoma Bank, Iowa
City, IA) at 1:1000. Alternatively, membranes were blocked with
5% BSA in TBST for 1 h at room temperature and were thereafter
incubated at 4◦C overnight with the following primary antibod-
ies: phospho-FOXO1 (Ser256, 9461, Cell Signaling Technology,
Danvers, MA) at 1:500; and phospho-FOXO3 (Ser253, 9466,
Cell Signaling Technology, Danvers, MA) at 1:400. FOXO1
and FOXO3 can be activated through phosphorylation by Akt
at Ser256 and Ser253, respectively, resulting in their nuclear
export and inhibition of transcription factor activity. Following
overnight primary antibody incubation, membranes were washed
with either PBS or TBST (4 × 5min) and were subsequently
incubated for 1 h with the following infrared-fluorescent conju-
gated secondary antibodies, diluted at 1:5000 in PBS or TBST
containing 50% Odyssey® Blocking Buffer (LI-COR Biosciences,
Lincoln, USA) and 0.01% SDS: IRDye 800CW goat anti-rabbit
IgG (LI-COR Biosciences, Lincoln, USA) for MURF1, FOXO1,
phospho-FOXO1, phospho-FOXO3, EIF3F, MYOD and PKM2;
IRDye 800CW donkey anti-goat IgG (LI-COR Biosciences,
Lincoln, USA) for FOXO3; and Alexa Fluor® 680 rabbit anti-
mouse IgG (Invitrogen, Carlsbad, CA) for FBXO40, myogenin,
MHC and GAPDH. After washing, the proteins were exposed
on an Odyssey® Infrared Imaging System (LI-COR Biosciences,
Lincoln, USA) and individual protein band optical densities were
determined using the Odyssey® Image Studio Lite Version 3.3.4.
All blots were normalized against the GAPDH protein (G8795;
Sigma-Aldrich, Sydney, Australia) (see Figure A1B). Extended
western blot pictures for the proteins myogenin, MYOD and
FOXO3 are represented in Figure A2.
RNA EXTRACTION AND REVERSE TRANSCRIPTION
RNAwas extracted from∼15mg of skeletal muscle samples using
Tri-Reagent® Solution (Ambion Inc., Austin, TX, USA) accord-
ing to the manufacturer’s protocol. The RNA concentration was
assessed using the Nanodrop 1000 Spectrophotometer (Thermo
Fisher Scientific, MA, USA). The ratio between A260/A280 was
1.75–1.95 for all samples. First-strand cDNA was generated from
1µg RNA in 20µl reaction buffer using the High Capacity RT-
kit (Applied Biosystems, Carlsbad, CA, USA), 1 × RT buffer and
random primers, 8mM dNTP and 2.5U µl−1 MultiScribeTM RT
enzyme. The RT protocol consisted of 10min at 25◦C, 120min at
37◦C, 5min at 85◦C then cooled to 4◦C. The cDNA was stored at
−20◦C until further analysis.
REAL-TIME PCR
Real-time PCR (RT-PCR) was carried out using a Stratagene
MX3000 thermal cycler to measure mRNA levels. mRNA lev-
els for atrogin-1, MURF1, FX040, FOXO1 and FOXO3 were
measured using 1 × SYBR® Green PCR MasterMix (Applied
Biosystems, Carlsbad, CA, USA) and 5 ng of cDNA. To compen-
sate for variations in input RNA amounts and efficiency of the
reverse transcription, data were normalized to cyclophilin (see
Figure A1A). All primers were used at a final concentration of
300 nM and probes at 100 nM. Primer details are provided in
Table 1. The PCR conditions were 1 cycle of 10min at 95◦C; 40
cycles of 30 s at 95◦C; 60 s at 60◦C. For cyclophilin, a melting
curve was included at the end of the PCR cycles. RT-PCR anal-
yses were conducted in triplicate. Ct values were obtained from
the MxPro QPCR software (Agilent Technologies, Santa Clara,
CA, USA). Mean Ct values and their standard error of the mean
(s.e.m.) were calculated for each of the samples. Ct values were
logarithmically transformed and mean log transformed Ct values
(referred to as arbitrary unit values) were then considered for
further analysis.
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Table 1 | PCR human primer sequences.
Gene GenBank accession number Sequences
MURF1 NM_032588.3 Forward CCTGAGAGCCATTGACTTTGG
Reverse CTTCCCTTCTGTGGACTCTTCCT
Probe (Texas Red)-AGGAAGAATTCATTGAAGAAGAAGATCAGG(BHQ-2)
FBXO32 (Atrogin-1) NM_058229.3 Forward GCAGCTGAACAACATTCAGATCAC
Reverse CAGCCTCTGCATGATGTTCAGT
Probe (FAM)-CTTCAAAGGCACCTTCACTGACCT G(BHQ-1)
FBXO40 NM_016298.3 Forward AGTCCACAGAGAGATCTG
Reverse TGTGCTCTACAATGTTGAA
Probe (HEX)-AGTTCAGCAGCCTCTTCTCCA(BHQ)
FOXO1 NM_002015 Forward AAGAGCGTGCCCTACTTCAA
Reverse CTGTTGTTGTCCATGGATGC
FOXO3 NM_001455 Forward CTTCAAGGATAAGGGCGACA
Reverse TCTTGCCAGTTCCCTCATT
PPIA (cyclophilin A) NM_021130 Forward CATCTGCACTGCCAAGACTGA
Reverse TTCATGCCTTCTTTCACTTTGC
MuRF1, muscle ring finger-1; FBXO32, F-box only protein 32/Atrogin-1, muscle atrophy F-box; FBXO40, F-box protein 40; FOXO1, forkhead transcription factor-1;
FOXO3, forkhead transcription factor-3; PPIA, peptidylprolyl isomerase A, cyclophilin A.
STATISTICAL METHODS
All data are reported as mean± s.e.m. Unless specified differently,
a Two-Way analysis of variance (ANOVA) for age and exercise was
used to compare group means. Diagnostic plots of residuals and
fitted values were checked to ensure homogeneity of variance (a
key assumption for ANOVA). Consequently, all data were log10-
transformed and analyses were conducted on these transformed
scales. The least significant difference (LSD) test was used to com-
pare pairs of means. The significance levels for both the F-tests in
the ANOVA and the LSD tests were set at p < 0.05.
RESULTS
SUBJECTS’ DEMOGRAPHICS
Table 2 summarizes the subjects’ physiological characteristics. No
significant difference in body mass, tissue composition and maxi-
mal voluntary contraction (1 RM) could be observed between the
two subjects groups.
GENE EXPRESSION WITH EXERCISE AND AGEING
In both younger and older subjects MURF1, atrogin-1 (FBXO32)
and FBXO40 mRNA levels were significantly increased 1.5-fold
and 1.3-fold (p < 0.05), 3.8-fold and 2-fold (p < 0.01) and
1.5-fold and 1.2-fold (p < 0.01), respectively, 2 h following RE
(Figure 1). In addition, FBXO40 mRNA levels were decreased by
25% in older subjects when compared to younger subjects (p <
0.01). Exercise and ageing had no effect on FOXO1 and FOXO3
mRNA levels (data not shown). No age × exercise interaction was
observed for any of the genes measured.
PROTEIN EXPRESSION WITH EXERCISE AND AGEING
A single-bout of RE did not influence the expression of any
of the proteins measured. In relation to the effect of age on
protein expression, FBXO40 protein levels were 1.5-fold higher
Table 2 | Subjects’ demographics.
Younger Older P-value
Age [years] 24.2 ± 0.9 66.6 ± 1.1 <0.05
Height [cm] 180.0 ± 2.0 174.60 ± 1.8 0.06
Body mass [kg] 73.8 ± 3.6 83.4 ± 7.1 0.25
Fat [kg] 13.6 ± 2.7 19.5 ± 3.9 0.23
Lean [kg] 57.9 ± 1.9 60.2 ± 3.3 0.55
BMC [kg] 3.3 ± 0.2 3.2 ± 0.2 0.67
BMI 23.3 ± 0.9 27.7 ± 1.9 0.10
Lean/total body mass 0.8 ± 0.02 0.7 ± 0.02 0.09
1 RM [kg] 98.2 ± 7.0 80.9 ± 7.2 0.1
Values are mean ± s.e.m. BMC, bone mass content; BMI, body mass
index; 1 RM, 1 repetition maximum. Statistical significance was determined by
unpaired Student’s t-tests.
in younger subjects than in older subjects (p < 0.01). We also
observed a trend (p = 0.051) for the effect of age on PKM2 pro-
tein levels, which were 1.6-fold higher in older subjects when
compared to younger subjects. Figure 2 depicts changes in pro-
tein expression as well as representative western blot pictures for
each protein measured.
DISCUSSION
Age-related muscle atrophy is linked to disrupted protein
turnover in MPS and MPB as well as reduced regenerative capac-
ity (Brack and Rando, 2007). When compared to younger sub-
jects, older subjects display an impaired phosphorylation of the
members of the MPS pathways at rest (Léger et al., 2008) and
impaired MPS following RE (Kumar et al., 2009), a phenomenon
referred to as anabolic resistance. However, how the UPP-related
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genes and proteins involved inMPB are regulated in older subjects
in response to RE and their potential contribution to anabolic
resistance is currently unknown.
Differences in the baseline expression levels of the skeletal
muscle MURF1 and atrogin-1 in younger vs. older individuals
is a contentious topic. This is due, at least partially, to the dis-
crepancies existing between the studied population cohorts in
terms of sex, age, physiological characteristics and level of fitness.
For example, it is commonly acknowledged that the older sub-
jects recruited on a voluntary basis for an exercise trial protocol
FIGURE 1 |MURF1, atrogin-1 (FBXO32) and FBXO40 mRNA expression
following a single-bout of resistance exercise in younger and older
people. Note that no changes were observed for the other genes
measured. ∗significant exercise effect, p < 0.05, ∗∗significant exercise
effect, p < 0.01, ##significantly different from Young, p < 0.01. The
reported statistical significance is based on analysis of the transformed data
but the reported means ± s.e.m. are on the original (untransformed) scale.
are not representative of the average elderly population and that
their average level of fitness is expected to be higher; a param-
eter that needs to be considered when comparing our results
to others. In the present study, we failed to observe an upreg-
ulation of MURF1 mRNA or protein in older subjects when
compared to younger subjects; a result in line with previous
results from our group (Léger et al., 2008) and others (Welle
et al., 2003; Whitman et al., 2005; Greig et al., 2011). However,
it has been reported that at baseline, MURF1 mRNA levels were
increased in older men displaying a similar average age and
level of fitness as our subjects (Dalbo et al., 2011), as well as
in much older women (>80 years) (Raue et al., 2007) when
compared to younger individuals. Consistent with previous find-
ings in humans, no age-related difference was found in the basal
level of atrogin-1 (FBXO32) mRNA (Welle et al., 2003; Whitman
et al., 2005; Raue et al., 2007; Léger et al., 2008; Dalbo et al.,
2011; Greig et al., 2011; Fry et al., 2013; Sandri et al., 2013).
Similarly, no age-dependent differences were observed at baseline
for FOXO1 and FOXO3 mRNA and protein or in the phosphory-
lation levels of FOXO1 and FOXO3 protein, the transcriptional
regulators of MURF1 and atrogin-1. Baseline FOXO3 mRNA
levels were increased in much older women (>80 years) com-
pared to younger women (Raue et al., 2007). At baseline, older
subjects had a lower cytosolic FOXO3 phosphorylation and a
higher total nuclear FOXO3 level compared to younger subjects
(Williamson et al., 2010); potentially resulting in more transcrip-
tional activity. However, we previously observed a decrease in
nuclear FOXO1 and FOXO3 protein in sarcopenic human skele-
tal muscle (Léger et al., 2008). Although we did not measure
nuclear proteins in this study, no differences in FOXO1 and
FOXO3 phosphorylation levels were observed between younger
FIGURE 2 | (A) FBXO40 and PKM2 protein expression following a
single-bout of resistance exercise in younger and older people. Note that
no changes were observed for the other proteins measured. ##significantly
different from Young, p < 0.01. The reported statistical significance is
based on analysis of the transformed data but the reported means ±
s.e.m. are on the original (untransformed) scale. (B) Representative
western blot images of the MURF1, total and phospho-FOXO1, total and
phospho-FOXO3, myogenin (MYOG), MYOD, MHC, and EIF3F proteins
measured before and after exercise. GAPDH was measured as a control
for protein loading.
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and older subjects. This suggests that the sub-cellular localization
of the FOXO proteins might not be a direct indication of their
activity.
Although other protein degradation mechanisms such as the
autophagy-lysosome system are unbalanced during age-related
muscle atrophy, at least in rodent muscle (for review see Bonaldo
and Sandri, 2013), our observations are consistent with recent
work demonstrating that the basal MPB rate does not signifi-
cantly differ with ageing (Volpi et al., 1999, 2000, 2001; Hasten
et al., 2000; Paddon-Jones et al., 2004; Cuthbertson et al., 2005;
Katsanos et al., 2005, 2006; Rasmussen et al., 2006; Kumar et al.,
2009). However, gene and protein expression analysis 2 h post-
exercise can not be reflective of the whole MPB process occurring
following RE. Further investigations that include a post-exercise
time course and direct measure of MPB obtained at similar time
points are therefore required. Basic limitations of mostMBPmea-
sures, including the AV balance approach, such as invasiveness,
possible inclusion of non-muscle tissue or potential variations
due to non-steady state conditions such as an exercise inter-
vention should yet be taken into account. Interestingly, genetic
deletion of atrogin-1 in rodents during ageing results in signif-
icant muscle atrophy and a shortened lifespan, while a reduced
muscle force occurs in both MURF1 and atrogin-1 aged knock-
out mice (Sandri et al., 2013); suggesting that these UPP genes
are essential for normal protein turnover during ageing (Sandri
et al., 2013).
MURF1, atrogin-1 and FBXO40 mRNA levels were all
increased by exercise, with no differential effect of exercise
between the age groups. MURF1 and atrogin-1 are typically reg-
ulated in response to a single-bout of RE. MURF1 mRNA is
commonly upregulated 1-4 h post-RE (Louis et al., 2007; Mascher
et al., 2008; Glynn et al., 2010). In contrast, some studies observed
no changes in atrogin-1 mRNA at 1–2 h post-exercise (Hulmi
et al., 2009; Glynn et al., 2010) or a decreased atrogin-1 mRNA
2 h post-exercise (Reitelseder et al., 2013). Raue et al. reported an
age effect in the increase of atrogin-1 mRNA, but not MURF1
mRNA, 4 h following RE in older women (>80 y.o.) (Raue et al.,
2007). However, in line with our findings, another study com-
paring similarly aged women to the study by Raue observed no
changes in MURF1 and atrogin-1 mRNA after 2.5 h of RE (Greig
et al., 2011). Again, different population cohorts and exercise pro-
tocols may lead to different or temporally shifted gene expression
patterns.
None of the proteins measured in this study displayed changes
in response to a single-bout of RE in any of the age groups.
The effects of single-bout RE on the protein levels and activ-
ity of FOXO1 and FOXO3 have only been partly described and
phosphorylation of FOXO3 was unaltered at 1 h following RE
(Glynn et al., 2010). However, MURF1 protein has been reported
to slightly increase at 1 h following bilateral leg extension exer-
cise (10 × 10 repetitions at 70% 1RM) (Glynn et al., 2010) and
at 3 h after unilateral leg press RE (4 × 10 repetitions at 80%
followed by 4 × 15 at 65% 1RM) (Borgenvik et al., 2012) in
untrained younger subjects; a difference that might be explained
by the lower intensity and total volume of work completed in
our study. Consistent with this result, the expression levels of
the MURF1 substrate targets PKM2 and MHC did not vary with
exercise. While atrogin-1 mRNA was induced by exercise, this
increase was not paralleled by a decrease in its substrate target
proteins MYOD, myogenin and EIF3F. A lack of visible change in
protein expression at 2 h post-exercise does not reflect a lack of
functional outcome. With respect to the delay existing between
gene transcription and protein translation, changes in protein
levels might occur later than 2 h post-exercise, as reported with
certain types of exercise protocols (Borgenvik et al., 2012). MPB
measured after a single-bout of RE has been shown to be max-
imal at 3 h post-exercise (Phillips et al., 1997), suggesting that
an increase in the proteolytic activity of MURF1 and atrogin-1
might occur concomitantly. In addition, E3-ubiquitin-ligases are
reported to self-ubiquinate, so that protein levels may not always
mirror mRNA levels (Sandri, 2013).
We report a decrease in FBXO40 gene and protein levels in
the muscle of older subjects when compared to younger subjects.
Similar to atrogin-1, FBXO40 is a gene encoding a muscle spe-
cific F-box protein (Ye et al., 2007). F-box proteins associate with
other proteins to form Skp1–Cullin1–F-box (SCF) complexes that
regulate proteasome-mediated protein breakdown via their ubiq-
uitin ligase activity. In skeletal muscle, FBXO40 ubiquitinates
and degrades insulin receptor substrate 1 (IRS1); the latter being
an upstream positive regulator of the PI3K/Akt pathway activity
(Shi et al., 2011). Mice lacking FBXO40 demonstrate abnormal
skeletal muscle hypertrophy. However, in humans, FBXO40 gene
expression decreases in the muscle of Limb-girdle muscular dys-
trophy (LGMD) patients (Ye et al., 2007). Attenuated FBXO40
expression in the skeletal muscle of older subjects might there-
fore reflect a compensatory mechanism to limit the amount of
age-related muscle wasting. It would be of interest to determine
if a resistance training intervention, potentially combined with
amino acid supplementation, would be able to rescue, at least par-
tially, the levels of FBXO40 in old muscle. Although we observed
no age-related change in MURF1 protein levels, PKM2 protein
expression tended to be higher in the older subjects when com-
pared to younger subjects. PKM2 is a substrate target for MURF1
(Hirner et al., 2008) and a molecular switch toward a more gly-
colytic phenotype fiber type (Gao and Cooper, 2013). A possible
hypothesis is that elevated PKM2 protein levels might account for
the reduced oxidative metabolism associated with muscle wasting
in older people (Rogers et al., 1990; Nair, 2005; Short et al., 2005),
even if oxidative metabolism or fiber type composition have not
been assessed in this study; however, PKM2 regulation is probably
multi-factorial.
In conclusion, we demonstrate that the UPP-related genes
involved in MPB display comparable regulation in healthy
younger and older subjects following RE. However, the lack of
significant difference in the physiological characteristics, body
composition and level of fitness of our older subjects when com-
pared to younger subjects must be considered when interpreting
these findings. We did not observe a change in the baseline levels
of atrogin-1 and MURF1 mRNA and protein of younger vs. older
individuals, but identified an age-related decline in FBXO40,
another recently described muscle specific F-box protein. Our
observations support the hypothesis that the UPP plays a limited
role in the disruption of the protein synthesis/degradation bal-
ance that is characteristic of age-related muscle atrophy. However,
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future investigations are required to measure skeletal MPB fol-
lowing RE in the ageing population. Additionally, measurements
of proteasomal content and/or proteasomal activity as well as
investigation of the role of other protein degradation mecha-
nisms, such as the autophagy-lysosome system, will aid in gaining
a deeper understanding of the contribution of the ubiquitin-
proteasome system in anabolic resistance.
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APPENDIX
FIGURE A1 | (A) Cyclophilin mRNA expression (AU), (B) GAPDH protein expression (AU) and representative blot for GAPDH protein analysis. IC, internal
control; Y, young; O, old.
FIGURE A2 | Representative western blots for the proteins myogenin (A), MYOD (B), and FOXO3 (C).
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